Cicloprolol
Alternative Names: SL 75177; SL 75177 10; SLD 177Latest Information Update: 14 May 1997
At a glance
- Originator Sanofi-Synthelabo
- Class
- Mechanism of Action Beta 1 adrenergic receptor agonists; Beta 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension; Ischaemic heart disorders
Most Recent Events
- 14 May 1997 Discontinued-preregistration for Heart failure in France (Unknown route)